Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 5 of 5 clinical reviews.
Does nicotine affect Repatha (evolocumab)? This evidence-based guide covers the pharmacokinetic interaction data, smoking's effect on LDL and cardiovascular risk, and what to tell your prescriber before starting evolocumab.
Read clinical reviewA clinical review of the evolocumab (Repatha) alcohol interaction profile, covering pharmacokinetics, liver enzyme effects, cardiovascular implications, and practical drinking guidance.
Read clinical reviewA comprehensive clinical review of the evolocumab (Repatha) and cannabis interaction profile, covering pharmacokinetic mechanisms, cardiovascular risk overlap, alcohol use, and evidence-based monitoring guidance.
Read clinical reviewA clinician-reviewed guide to whether evolocumab (Repatha) interacts with iodinated or gadolinium contrast agents used in CT, MRI, and cardiac imaging. Includes dosing guidance, alcohol use, and general drug interaction data.
Read clinical reviewA complete clinical review of evolocumab (Repatha) and vaccine interactions, alcohol use, and drug interactions. Includes FDA label guidance, primary literature citations, and a practical dosing framework.
Read clinical review